Grant List
Represents Grant table in the DB
GET /v1/grants?page%5Bnumber%5D=1393&sort=-awardee_organization
{ "links": { "first": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1&sort=-awardee_organization", "last": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1442&sort=-awardee_organization", "next": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1394&sort=-awardee_organization", "prev": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1392&sort=-awardee_organization" }, "data": [ { "type": "Grant", "id": "5966", "attributes": { "award_id": "1R21AI164007-01", "title": "Cross-reactivity of SARS-CoV-2 with coronaviruses isolated from humans in Haiti", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [ { "id": 20423, "first_name": "Mary Chelsea", "last_name": "Lane", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2021-06-21", "end_date": "2023-05-31", "award_amount": 228750, "principal_investigator": { "id": 20424, "first_name": "John Glenn", "last_name": "Morris", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [], "awardee_organization": { "id": 158, "ror": "https://ror.org/02y3ad647", "name": "University of Florida", "address": "", "city": "", "state": "FL", "zip": "", "country": "United States", "approved": true }, "abstract": "In many parts of the world, including most developed countries, COVID19 has had a major impact on morbidity and mortality, with over 35 million cases and over 1 million deaths reported to WHO at the time of submission of this proposal. However, there are also observations suggesting that severe disease and death have occurred less frequently in certain countries and regions, including, in particular, parts of Africa. While this perceived decrease in severity of illness may simply be a reporting artifact, it has been suggested that this decrease in severity is due to pre-existing immunity within these populations, based on prior exposure to viruses which cross-react with SARS-CoV-2. The first COVID19 case was identified in Haiti on March 19, 2020. New cases peaked during the first week of June, with a gradual decline to almost none by September; as of the beginning of October, Haiti has reported a total of 8,792 confirmed infections and 229 COVID-related deaths. It is likely that the number of reported cases in Haiti grossly underestimates the actual number of infections, due to limitations in laboratory testing capacity. Support for a much higher actual case number comes from clinical observations, and a reported test positivity rate of >80% among samples from symptomatic individuals. However, the onslaught of severe cases and deaths which was expected to follow the case peak has not occurred, raising the possibility of some level of pre-existing immunity in this population. Our research group has been engaged in NIH-supported virus discovery studies in Haiti for the past 5 years. We have isolated and sequenced multiple coronaviruses from human blood samples, including human endemic coronaviruses and two previously undescribed coronaviruses that may have a zoonotic origin. We hypothesize that the decrease in severity of illness associated with SARS-CoV-2 in Haiti is a function of cross- reactivity to one or more viruses circulating in Haiti, including, possibly, these coronaviruses. In this exploratory R21 we will make use of pre- and post-COVID blood samples from an existing cohort of Haitian women and from U.S. controls to look for evidence of prior immunity to SARS-CoV-2 and cross-reactivity to the coronaviruses which we have identified. Specific Aims include: Specific Aim 1: Screening of pre-COVID serum samples from a cohort of Haitian women and U.S. controls for the presence of neutralizing antibody to SARS-CoV-2 and Haitian coronaviruses; Specific Aim 2: Screening for cross-reacting antibodies directed against Haitian coronaviruses among women infected with SARS-CoV-2; and Specific Aim 3: Screening for T-cell activation directed against Haitian coronaviruses isolated from humans.", "keywords": [ "2019-nCoV", "Africa", "Age", "Animals", "Antibodies", "Blood", "Blood specimen", "COVID-19", "Case Study", "Cellular Immunity", "Cessation of life", "Clinical", "Cohort Studies", "Collaborations", "Coronavirus", "Country", "Developed Countries", "Development", "Disease", "Dominican Republic", "Elements", "Exposure to", "Fever", "Funding", "Genetic", "Geographic Locations", "Haiti", "Haitian", "Hospitals", "Human", "Humoral Immunities", "Immunity", "Individual", "Infection", "Kaposi Sarcoma", "Laboratories", "Morbidity - disease rate", "Morphologic artifacts", "Opportunistic Infections", "Outcome", "Persons", "Population", "Public Health", "Recovery", "Reporting", "Research", "Reverse Transcriptase Polymerase Chain Reaction", "SARS-CoV-2 antibody", "SARS-CoV-2 immunity", "SARS-CoV-2 infection", "Sampling", "Serum", "Severities", "Severity of illness", "Structure", "T-Cell Activation", "Testing", "Time", "United States National Institutes of Health", "Viral", "Virus", "Vital Statistics", "Woman", "Zoonoses", "cohort", "coronavirus disease", "cross reactivity", "human coronavirus", "mortality", "neutralizing antibody", "novel coronavirus", "pandemic disease", "population based", "screening" ], "approved": true } }, { "type": "Grant", "id": "6261", "attributes": { "award_id": "3U54AI142766-03S1", "title": "Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC)", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [ { "id": 21179, "first_name": "Kentner L.", "last_name": "Singleton", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2020-09-08", "end_date": "2022-06-30", "award_amount": 1351492, "principal_investigator": { "id": 21180, "first_name": "MARK A.", "last_name": "ATKINSON", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [ { "id": 21181, "first_name": "Bernd", "last_name": "Bodenmiller", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, { "id": 21182, "first_name": "HARRY S", "last_name": "NICK", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "awardee_organization": { "id": 158, "ror": "https://ror.org/02y3ad647", "name": "University of Florida", "address": "", "city": "", "state": "FL", "zip": "", "country": "United States", "approved": true }, "abstract": "Extensive clinical research studies are urgently needed to inform patient management strategies and develop pharmaceutical countermeasures to combat the 2019 novel coronavirus disease (COVID-19). Currently, COVID-19 infections and hospitalizations are surging across the state of Florida; hence, we propose to establish the University of Florida (UF) as a subject-enrollment and sample collection center for the Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC) study at three Florida health science centers. In this nationwide prospective observational study, peripheral blood and nasal swabs will be frequently collected from consented hospitalized patients with confirmed COVID-19, with endotracheal aspirates also collected if the patient requires intubation. After participants are discharged, blood and nasal swabs will be collected during outpatient visits held at three-month intervals over the course of one year, allowing for longitudinal analysis of the virus’s effects on the immune system both during active infection and following recovery. Through the OneFlorida Clinical Research Consortium (CRC), we already have established infrastructure including trained staff to support participant consenting/enrollment and sample collection, as well as on site laboratory facilities for sample processing. In Aim 1, we propose to integrate three OneFlorida CRC collection sites (Tampa General Hospital/University of South Florida, UF Health Jacksonville Medical Center, and UF Health Shands Hospital in Gainesville) into the IMPACC study. These sites have sufficient COVID-19 caseload to support enrollment of 100 participants over the course of the four-month recruitment period. In Aim 2, samples will be processed immediately upon collection and shipped to six core laboratories for precision medicine genotyping, viral sequencing, proteomics/metabolomics, antibody measurement and isotyping, as well as immunophenotyping by CyTOF. From these collective data, IMPACC seeks to link viral burden with immune signatures as biomarkers of acute disease severity, mortality, the development of durable immunity, and long-term outcomes in survivors. Moreover, extensive immunophenotyping data has the potential to uncover new therapeutic targets to mitigate the disease severity. Initially, COVID-19 mortality was attributed to a cytokine storm and enhanced thrombosis, supporting treatment with immunosuppressive drugs in patients with severe disease. However, in an effort to support the power of immmuophenotyping to provide key information, we provide preliminary data suggesting that immunosuppression is a primary concordant feature of the disease, potentially arguing against the routine use of immunosuppressant medications. These data also demonstrate our ability to perform single cell RNA sequencing (scRNAseq), scATACseq, spectral flow cytometry, and ELISpot to evaluate gene expression, chromatin accessibility, protein expression, and immune cell function, respectively. With the consortium’s approval to use residual IMPACC samples, these site-specific assays could be funded through outside mechanisms and the data shared across the IMPACC consortium.", "keywords": [ "2019-nCoV", "Acute", "Acute Disease", "Adult", "Antibodies", "Aspirate substance", "Biological Assay", "Biological Markers", "Blood", "COVID-19", "COVID-19 pandemic", "Cell physiology", "Chromatin", "Clinical Research", "Cohort Studies", "Collection", "Consent", "Core Facility", "Data", "Development", "Disease", "Enrollment", "Florida", "Flow Cytometry", "Funding", "Gene Expression", "General Hospitals", "Generations", "Genotype", "Health", "Health Sciences", "Hospitalization", "Hospitals", "Immune", "Immune system", "Immunity", "Immunologics", "Immunophenotyping", "Immunosuppression", "Immunosuppressive Agents", "Infection", "Infrastructure", "Intubation", "Laboratories", "Link", "Measurement", "Medical History", "Medical center", "National Institute of Allergy and Infectious Disease", "Nose", "Observational Study", "Outcome", "Outpatients", "Participant", "Patients", "Pharmaceutical Preparations", "Pharmacologic Substance", "Physiological", "Process", "Prospective cohort", "Proteomics", "Public Health", "Recovery", "Residual state", "Sampling", "Severity of illness", "Ships", "Site", "Survivors", "Swab", "Therapeutic Intervention", "Thrombosis", "Training", "Universities", "University Hospitals", "Viral", "Viral Load result", "Virus", "Visit", "cohort", "combat", "coronavirus disease", "cytokine release syndrome", "data sharing", "endotracheal", "laboratory facility", "longitudinal analysis", "metabolomics", "mortality", "new therapeutic target", "peripheral blood", "precision medicine", "prospective", "protein expression", "recruit", "research study", "sample collection", "single-cell RNA sequencing", "targeted treatment" ], "approved": true } }, { "type": "Grant", "id": "6336", "attributes": { "award_id": "3R01DE025832-05S1", "title": "Probiotics that moderate pH and antagonize pathogens to promote oral health", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Dental and Craniofacial Research (NIDCR)" ], "program_reference_codes": [], "program_officials": [ { "id": 21363, "first_name": "Tamara L", "last_name": "McNealy", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2020-08-01", "end_date": "2023-02-28", "award_amount": 215292, "principal_investigator": { "id": 21364, "first_name": "Robert A", "last_name": "Burne", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 158, "ror": "https://ror.org/02y3ad647", "name": "University of Florida", "address": "", "city": "", "state": "FL", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 158, "ror": "https://ror.org/02y3ad647", "name": "University of Florida", "address": "", "city": "", "state": "FL", "zip": "", "country": "United States", "approved": true }, "abstract": "Abstract/Summary Commensal oral streptococci are the most abundant bacteria in the biofilms that colonize the hard and soft tissues of the human oral cavity and many areas of the nasopharynx. These health-associated bacteria employ multiple diverse adhesion strategies and produce a spectrum of compounds and macromolecules that inhibit the colonization and virulence of pathogens. With support from R01 DE25832, a large collection of commensal oral streptococci has been isolated from healthy subjects, then characterized at the phenotypic and genomic levels for properties that may promote oral and systemic health. Here, we propose to screen these highly diverse strains for their ability to bind to and degrade purified SARS-CoV-2 surface proteins and to interfere with CoV-2 Spike protein engagement of the viral receptor, ACE2. Standard methods will then be used to identify the streptococcal gene products that mediate inhibitory activities. Defined mutants and overexpressing strains will be utilized to confirm the results. Though not a focus of this Urgent Revision application, it is noteworthy that, as part of DE25832, we have developed a mouse model in which we can establish various commensal streptococci in the oral cavity, then challenge the commensal-colonized mice with a pathogen(s). Such a model could be adapted to in vivo animal challenge studies. Importantly, novel systems for formulation and delivery of one of our commensal strains have already been optimized through an international collaboration, and thus we are well positioned to rapidly translate our in vitro findings to clinical trials of a therapeutic probiotic intervention.", "keywords": [ "2019-nCoV", "Adhesions", "Affinity", "Animals", "Antigens", "Antiviral Agents", "Area", "Arginine", "Award", "Bacteria", "Binding", "Biological", "COVID-19", "Clinical", "Clinical Trials", "Collaborations", "Collection", "Dental caries", "Detection", "Enzymes", "Etiology", "Formulation", "Foundations", "Generations", "Genetic", "Genetic Markers", "Genomics", "Health", "Human", "Hydrogen Peroxide", "Immunologics", "In Vitro", "Individual", "International", "Intervention", "Lead", "Mediating", "Membrane Proteins", "Metabolic", "Metabolism", "Methods", "Microbial Biofilms", "Modeling", "Monitor", "Morbidity - disease rate", "Mus", "Nasopharynx", "Oral", "Oral cavity", "Oral health", "Oxidases", "Parents", "Peptide Hydrolases", "Phenotype", "Positioning Attribute", "Probiotics", "Property", "Proteins", "Reagent", "Respiratory Tract Infections", "Rodent Model", "Severities", "Source", "Streptococcus", "Streptococcus mutans", "Surface", "System", "Testing", "Translating", "Viral", "Viral Pathogenesis", "Virulence", "Virus", "Virus Diseases", "Virus Receptors", "bacteriocin", "commensal bacteria", "comparative genomics", "dental biofilm", "functional genomics", "gene product", "human tissue", "in vivo", "macromolecule", "member", "metatranscriptomics", "microbiome", "mortality", "mouse model", "mutant", "novel", "novel therapeutics", "oral commensal", "oral pathogen", "oral streptococci", "oral tissue", "overexpression", "pathogen", "prevent", "probiotic therapy", "receptor", "soft tissue" ], "approved": true } }, { "type": "Grant", "id": "6399", "attributes": { "award_id": "3U01AA020797-10S1", "title": "Effects of experimentally-induced reductions in alcohol consumption on brain cognitive, and clinical outcomes and motivation for changing drinking in older persons with HIV infection", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute on Alcohol Abuse and Alcoholism (NIAAA)" ], "program_reference_codes": [], "program_officials": [ { "id": 21525, "first_name": "Joe", "last_name": "Wang", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2011-09-25", "end_date": "2022-06-30", "award_amount": 133466, "principal_investigator": { "id": 21526, "first_name": "RONALD A", "last_name": "COHEN", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [ { "id": 21527, "first_name": "Robert L", "last_name": "Cook", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "awardee_organization": { "id": 158, "ror": "https://ror.org/02y3ad647", "name": "University of Florida", "address": "", "city": "", "state": "FL", "zip": "", "country": "United States", "approved": true }, "abstract": "Persons living with HIV (PLWH) are an especially vulnerable population in the COVID-19 pandemic given their compromised immune system and comorbidities (e.g., substance use, mental health issues). Currently, no research has examined how the broad impacts of COVID-19 (e.g., extended social isolation, anxiety, family loss) are affecting alcohol use and care engagement in PLWH. Further, it is unclear whether these impacts affect cognition or the brain. This urgent supplement will allow us to capture this window of opportunity and collect timely data to address these gaps. Our ongoing U01 study of a cohort consisting of PLWH and persons without HIV focusing on using a contingency management protocol to reduce alcohol consumption provides many unique strengths to support this supplement. This supplement is within the scope of the parent grant but extents the parent study by incorporating COVID-19-related questions/measures into the ongoing data collection. We will collect additional data through questionnaires, electronic at-home cognitive testing via CANTAB Connect, stress severity quantification via cortisol analysis of hair samples, and qualitative interviews. We will also conduct COVID-19 antibody tests (through blood samples) and MRIs that we conduct as part of the parent grant procedure. The specific aims of this supplement include: 1) Determine the influence of specific psychosocial factors (e.g., social isolation, loneliness, anxiety, and food and housing insecurity) on alcohol use trajectory and HIV-related health behavior and outcomes (ART adherence, and health care engagement) during the period of the pandemic and social distancing. We will also examine which baseline factors (e.g., clinical, demographic, neuroimaging, cognitive) best predict individual differences in outcome; 2) Assess the feasibility and acceptability of (1) an at-home, electronically delivered neurocognitive assessment on the CANTAB Connect system and (2) participant mail-in hair samples. For those willing and able to complete one or both of these measures, we will examine the relationships of the psychosocial factors assessed in Aim 1 on cognitive performance and/or stress severity as measured by cortisol levels from hair samples obtained from participants; 3) Obtain additional neuroimaging from participants to ensure we have data from both before and after the coronavirus crisis, and (should there be sufficient prevalence), determine whether participants found to have been infected with COVID-19 (with or without symptoms) have a greater extent of white matter hypersensitivity (WMH) on FLAIR brain MRI, along with other associated structural, functional, and metabolic brain changes (fMRI, MRS); and an exploratory aim to will conduct a qualitative interview to explore factors that are subjectively judged to be interfering with drinking abstinence and HIV medication adherence, and what might help in this regard. These results will provide valuable evidence on how the COVID-19 pandemic affects alcohol use and HIV care, in addition to changes in cognition and the brain, which can potentially inform future prevention and treatment programs during future emergency situations.", "keywords": [ "2019-nCoV", "Abstinence", "Address", "Adherence", "Administrative Supplement", "Adverse effects", "Affect", "Aging", "Alcohol consumption", "Alcohol dependence", "Alcohol or Other Drugs use", "Alcohols", "Antibodies", "Anxiety", "Behavior", "Behavioral", "Biological", "Biological Markers", "Blood specimen", "Brain", "COVID-19", "COVID-19 pandemic", "Caring", "Clinical", "Clinical Trials", "Cognition", "Cognitive", "Collection", "Coronavirus", "Country", "Data", "Data Collection", "Development", "Elderly", "Emergency Situation", "Enrollment", "Ensure", "Family", "Food", "Functional Magnetic Resonance Imaging", "Future", "HIV", "HIV Infections", "Hair", "Health", "Health behavior outcomes", "Healthcare", "Heavy Drinking", "Home environment", "Housing", "Hydrocortisone", "Hypersensitivity", "Immune system", "Individual", "Individual Differences", "Interruption", "Intervention", "Interview", "Loneliness", "MRI Scans", "Magnetic Resonance Imaging", "Measures", "Mental Health", "Metabolic", "Motivation", "Neurocognitive", "Outcome", "Parents", "Participant", "Persons", "Physiological", "Population", "Prevalence", "Prevention program", "Procedures", "Protocols documentation", "Psychosocial Factor", "Public Health", "Questionnaires", "Relapse", "Research", "Research Project Grants", "Sampling", "Self Administration", "Severities", "Social Distance", "Social isolation", "Stress", "Stress Tests", "Structure", "Symptoms", "System", "Telephone", "Testing", "Time", "Treatment/Psychosocial Effects", "United States National Institutes of Health", "Update", "Videoconferences", "Vulnerable Populations", "White Matter Hyperintensity", "aging population", "alcohol abstinence", "antiretroviral therapy", "base", "behavioral/social science", "care outcomes", "clinically significant", "co-infection", "cognitive performance", "cognitive testing", "cohort", "comorbidity", "contingency management", "drinking", "experience", "financial incentive", "follow-up", "health care service utilization", "improved", "interest", "medication compliance", "neuroimaging", "pandemic disease", "parent grant", "parent project", "participant retention", "primary outcome", "psychologic", "psychosocial", "response", "social engagement", "social stress", "stressor", "therapy adherence", "treatment program", "white matter" ], "approved": true } }, { "type": "Grant", "id": "6400", "attributes": { "award_id": "3U24AA022002-08S1", "title": "Southern HIV and Alcohol Research Consortium Administrative and Research Support Core", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute on Alcohol Abuse and Alcoholism (NIAAA)" ], "program_reference_codes": [], "program_officials": [ { "id": 21528, "first_name": "Deidra", "last_name": "Roach", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2012-09-25", "end_date": "2023-03-31", "award_amount": 152332, "principal_investigator": { "id": 21529, "first_name": "Robert L", "last_name": "Cook", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [], "awardee_organization": { "id": 158, "ror": "https://ror.org/02y3ad647", "name": "University of Florida", "address": "", "city": "", "state": "FL", "zip": "", "country": "United States", "approved": true }, "abstract": "It is not clear whether the coronavirus (COVID-19) pandemic has differentially affected HIV outcomes or drinking behavior among rural or ethnic minority populations. Understanding how COVID-19 changes HIV care and alcohol use could strengthen future HIV and alcohol care delivery to increase the resilience of these programs. Access to health research is also adversely affected by COVID-19. This shift to telehealth has potential to help clinicians and researchers connect with hard-to-reach populations. However, we need to understand feasibility and acceptability of telehealth by persons living with HIV (PLWH) if we are to extend research and improve delivery of alcohol interventions and HIV care in the future. This request is supplementary to U24AA022002, providing supportive infrastructure to the Southern HIV Alcohol Research Consortium (SHARC), including the FL Cohort. The objective of the FL Cohort is to better understand barriers and facilitators to viral suppression, focusing on alcohol use. However, the planned FL Cohort will not be able to distinguish if changes in alcohol use or HIV care are due to COVID-19, and will not have sufficient persons from rural or Haitian communities to assess differential effects in these underserved populations. This supplement will help determine how COVID-related social isolation and COVID disease have influenced the HIV care continuum, alcohol use and treatment, and acceptance of telehealth, stated interests in NOT-AA-20- 011 and high priority HIV research areas. The aims of this supplement are to: 1) Determine the impacts of COVID disease and related changes in psychosocial factors (e.g., loneliness, social support, economic insecurity, domestic violence) on alcohol use and HIV-related care and health outcomes (ART adherence, care engagement, and viral suppression) as assessed before and during social distancing measures; 2) Extend FL Cohort recruitment into rural areas and the Haitian community, and compare the psychosocial effects, changes in drinking, and HIV-related outcomes in rural vs. urban settings and within the Haitian community. 3) Assess the feasibility, acceptability, and interest in remote enrollment and data collection for research, and delivery of alcohol interventions and HIV clinical care among patients and providers, and compare optimal strategies across socio-demographic groups (e.g., age cohort, rural vs. urban, ethnic groups). We will accomplish these aims by adding an additional COVID-related questionnaire to the existing measures in the parent FL Cohort study, recruiting and additional 150 persons from rural areas and the Haitian community who will complete a single, “light” version of the study, and conducting qualitative interviews from PLWH and healthcare personnel to better understand how we can learn from the crisis to adapt new interventions. The study will have impact by directly informing strategies related to implementation of alcohol and HIV interventions, by expanding our knowledge related to the impact of a new infectious disease pandemic on drinking and HIV outcomes, and by enhancing the overall representativeness of our cohort sample.", "keywords": [ "AIDS/HIV problem", "Adherence", "Affect", "Age", "Alcohol consumption", "Alcohols", "Americas", "Area", "COVID-19", "COVID-19 pandemic", "Caring", "Clinical", "Cohort Studies", "Communicable Diseases", "Communities", "Continuity of Patient Care", "Coronavirus", "County", "Data", "Data Collection", "Data Reporting", "Disease", "Domestic Violence", "Economics", "Elderly", "Enrollment", "Epidemic", "Ethnic group", "Event", "Florida", "Funding", "Future", "HIV", "Haitian", "Health", "Health Personnel", "Healthcare", "Incidence", "Infrastructure", "Intervention", "Interview", "Knowledge", "Learning", "Left", "Light", "Loneliness", "Measures", "Medical", "Outcome", "Parents", "Participant", "Patient Self-Report", "Patients", "Persons", "Population", "Populations at Risk", "Positioning Attribute", "Prevalence", "Provider", "Psychosocial Factor", "Questionnaires", "Reporting", "Research", "Research Activity", "Research Personnel", "Research Support", "Resources", "Rural", "Rural Minority", "Sampling", "Shock", "Social Distance", "Social isolation", "Social support", "State Interests", "System", "Telemedicine", "Treatment/Psychosocial Effects", "Underserved Population", "Viral", "Visit", "Vulnerable Populations", "Work", "alcohol abuse therapy", "alcohol intervention", "alcohol misuse", "alcohol research", "care delivery", "care outcomes", "clinical care", "cohort", "comorbidity", "coronavirus disease", "drinking", "drinking behavior", "ethnic minority population", "experience", "improved", "interest", "member", "novel coronavirus", "pandemic disease", "programs", "recruit", "resilience", "rural area", "rural setting", "rural underserved", "sociodemographic group", "surveillance data", "telehealth", "treatment program", "urban setting" ], "approved": true } }, { "type": "Grant", "id": "6401", "attributes": { "award_id": "3R01DA042069-04S1", "title": "Health outcomes and cognitive effects of marijuana use among persons living with HIV/AIDS", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute on Drug Abuse (NIDA)" ], "program_reference_codes": [], "program_officials": [ { "id": 21530, "first_name": "Shelley", "last_name": "Su", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2017-08-15", "end_date": "2022-03-31", "award_amount": 148760, "principal_investigator": { "id": 21531, "first_name": "Robert L", "last_name": "Cook", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [], "awardee_organization": { "id": 158, "ror": "https://ror.org/02y3ad647", "name": "University of Florida", "address": "", "city": "", "state": "FL", "zip": "", "country": "United States", "approved": true }, "abstract": "Persons living with HIV (PLWH) are an especially vulnerable population in the COVID-19 pandemic given their compromised immune system and comorbidities (e.g., substance use, mental health issues). Currently, no research has examined how the broad impacts of COVID-19 (e.g., extended social isolation, anxiety, family loss) are affecting marijuana use, cannabis use disorder (CUD), and care engagement in PLWH. Further, research has not clarified whether chronic marijuana use will interact with HIV infection to impact the onset and progression of COVID-19 infection. This urgent supplement will allow us to capture this window of opportunity and collect timely data to address these gaps. Our ongoing R01 study of a PLWH cohort focusing on marijuana use provides many unique strengths to support this supplement. The primary goal of the active R01 project is to examine the long-term impact of marijuana use on cognitive functioning and health outcomes in a cohort of PLWH (currently 300 participants completed baseline assessment) in Florida. This supplement is within the scope of the parent grant but extends the parent study by incorporating COVID-19-related questions/measures into the ongoing data collection. We will collect additional data using a mixed method approach which includes quantitative survey questions and in-depth qualitative interviews on a selected subsample. We will conduct COVID-19 antibody tests using the blood sample we collect as a part of the parent grant procedures. We will also link the collected data with the Florida Department of Health EHARS data on HIV-related outcomes (e.g., viral load) over time, which is also a part of the parent study. The specific aims of this supplement include: 1) To identify the impact of the COVID-19 pandemic on changes in marijuana use and cannabis use disorder (CUD) among PLWH; 2) To determine the impact of the COVID-19 pandemic on the HIV care continuum (i.e., HIV care engagement) and outcomes (i.e., viral load); and 3) To estimate the prevalence of COVID-19 infection in our study sample after September 2020, using antibody testing for IgG and IgM. If we have a large enough sample (i.e., 10% tested positive for COVID-19), we will examine the association between marijuana use status and COVID-19 incidence/severity. This study will be the first to address the impacts of the COVID-19 pandemic among an ongoing cohort of PLWH with a focus on marijuana use and its related health outcomes. By collecting additional COVID-19-related information as a part of the regular follow-ups in the parent study, we will be able to provide valuable evidence on how the COVID-19 pandemic may cause changes in PLWH’s marijuana use/CUD and HIV care/outcomes and will be able to identify the underlying mechanism of these changes. Results from the antibody tests may also provide informative data on whether marijuana use interacts with HIV in affecting COVID-19 incidence and severity, which can potentially inform future prevention and treatment programs for COVID-19 in this population.", "keywords": [ "AIDS/HIV problem", "Address", "Adult", "Affect", "African American", "Alcohol or Other Drugs use", "Antibodies", "Anxiety", "Blood specimen", "COVID-19", "COVID-19 pandemic", "Caring", "Chronic", "Chronic Disease", "Cognitive", "Continuity of Patient Care", "Data", "Data Collection", "Dimensions", "Economics", "Enrollment", "Epidemic", "Family", "Florida", "Future", "Goals", "HIV", "HIV Infections", "Health", "Immune system", "Immunoglobulin G", "Immunoglobulin M", "Incidence", "Infection", "Inflammation", "Interview", "Link", "Location", "Longitudinal cohort", "Measures", "Mental Depression", "Mental Health", "Methods", "Minority", "Occupational", "Outcome", "Parents", "Participant", "Persons", "Population", "Post-Traumatic Stress Disorders", "Prevalence", "Prevention program", "Preventive Intervention", "Procedures", "Research", "Sampling", "Sampling Studies", "Severities", "Social isolation", "Substance Use Disorder", "Surveys", "Testing", "Therapeutic", "Time", "Viral", "Viral Load result", "Visit", "Vulnerable Populations", "care outcomes", "cognitive function", "cohort", "comorbidity", "coronavirus disease", "experience", "follow-up", "intervention program", "marijuana use", "marijuana use disorder", "parent grant", "psychosocial", "public health emergency", "social", "surveillance data", "treatment program" ], "approved": true } }, { "type": "Grant", "id": "6406", "attributes": { "award_id": "3U01DA051126-01S1", "title": "National Drug Early Warning System (NDEWS) COVID-19 Supplement", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute on Drug Abuse (NIDA)" ], "program_reference_codes": [], "program_officials": [ { "id": 21544, "first_name": "Marsha", "last_name": "Lopez", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2020-04-01", "end_date": "2025-02-28", "award_amount": 130357, "principal_investigator": { "id": 21545, "first_name": "Linda B.", "last_name": "Cottler", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 158, "ror": "https://ror.org/02y3ad647", "name": "University of Florida", "address": "", "city": "", "state": "FL", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 158, "ror": "https://ror.org/02y3ad647", "name": "University of Florida", "address": "", "city": "", "state": "FL", "zip": "", "country": "United States", "approved": true }, "abstract": "OF PARENT GRANT AND PROPOSED SUPPLEMENT Parent Study: Through our parent U01, our National Drug Early Warning System (NDEWS) Coordinating Center aims to provide NIDA and the field with the most timely, salient, and valuable information on emerging substance use trends. By expanding data collection to include both former NDEWS sentinel sites as well as former Community Epidemiology Workgroup (CEWG) sites, and by incorporating novel surveillance methods to ensure early detection of signals of new psychoactive substances and known substances, our Early Warning Network extends geographic representation and provides a more complete picture of the size, direction, and depth of substance use patterns in all US Census regions. We will use novel surveillance methods to ensure early detection of signals indicating emerging drug trends and harmonize surveillance data across sentinel and CEWG sites. We will also conduct on-the-ground epidemiologic investigations on topics of immediate crisis or need in order to provide functional feedback to impacted communities towards optimizing current and future response, and we will disseminate results rapidly to the scientific community and the public alike. Proposed Supplement: The current COVID-19 crisis underscores a need for rapid assessments of the virus’s impact in substance-using populations throughout the NDEWS Early Warning Network, as people who use drugs appear to be at increased risk for COVID-19-related adverse outcomes and may find it more difficult to get care during the crisis. In addition, COVID-19 may alter one’s exposure to drug use, certain drugs, or might change patterns of drug use altogether. As an Early Warning System, NDEWS must be on the forefront of new trends in drug use, drug-related mortality, and drug treatment utilization, all of which may be either directly or indirectly impacted by COVID-19. Although in-person human subjects research has been halted, COVID-19 focused efforts that must begin now—with creative strategies that allow for immediate data to assess the impact of COVID-19 on substance use behaviors. In this proposed study, we will (Aim 1) collect rapid response data on substance use-related consequences of COVID-19 from novel key informants across the country in the urban, rural, and suburban areas represented by the 18 Early Warning Network sites, focused on decedents, family members of decedents, and the community at large. Key informants will include 1) funeral directors (n=200), 2) emergency medical service personnel (n=200), and 3) syringe exchange workers (n=75). We will (Aim 2) detect trends in patterns of drug-related mortality, health services utilization, including overdose reversals, and syringe exchange services by following up with key informants at 2, 3, 4, and 5 months post- baseline. We will then (Aim 3) rapidly disseminate the data to NIDA, through media outreach, and contribute to science through peer-reviewed publications. At a time when we cannot physically recruit or survey participants in person due to the COVID-19 crisis, we believe this is an extraordinary opportunity to collect rich data from key informants nationwide. Results will provide targets for new research strategies and prevention efforts.", "keywords": [ "2019-nCoV", "Administrative Supplement", "Alcohol or Other Drugs use", "Area", "Behavior", "COVID-19", "Caring", "Censuses", "Communities", "Country", "Data", "Data Collection", "Drug usage", "Drug user", "Early Diagnosis", "Emergency Health Services", "Emergency medical service", "Emergency response", "Ensure", "Epidemiology", "Event", "Exposure to", "Family member", "Feedback", "Florida", "Future", "Geography", "Health Services", "Height", "Human Resources", "Human Subject Research", "Institution", "Interview", "Investments", "Knowledge", "Measures", "Modification", "Naloxone", "National Institute of Drug Abuse", "Needle-Exchange Programs", "New York", "Overdose", "Paramedical Personnel", "Parents", "Participant", "Pattern", "Peer Review", "Persons", "Pharmaceutical Preparations", "Pharmacotherapy", "Population", "Positioning Attribute", "Prevention", "Public Health", "Publications", "Research", "Research Proposals", "Resources", "Risk", "Rural", "Sampling", "Science", "Sentinel", "Signal Transduction", "Site", "Social Distance", "Source", "Structure", "Surveillance Methods", "Surveys", "System", "Time", "Universities", "Virus", "addiction", "adverse outcome", "epidemiology study", "experience", "first responder", "follow-up", "health service use", "human subject", "improved", "informant", "insight", "mortality", "novel", "novel strategies", "operation", "outreach", "pandemic disease", "parent grant", "prospective", "recruit", "response", "suburb", "surveillance data", "trend" ], "approved": true } }, { "type": "Grant", "id": "6474", "attributes": { "award_id": "3R01DE025001-05S1", "title": "Novel coatings to minimize surface degradation and fracture susceptibility of dental ceramics", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Dental and Craniofacial Research (NIDCR)" ], "program_reference_codes": [], "program_officials": [ { "id": 21733, "first_name": "Orlando", "last_name": "Lopez", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2016-06-13", "end_date": "2021-09-30", "award_amount": 219405, "principal_investigator": { "id": 21734, "first_name": "Josephine F.", "last_name": "Esquivel-Upshaw", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 158, "ror": "https://ror.org/02y3ad647", "name": "University of Florida", "address": "", "city": "", "state": "FL", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 158, "ror": "https://ror.org/02y3ad647", "name": "University of Florida", "address": "", "city": "", "state": "FL", "zip": "", "country": "United States", "approved": true }, "abstract": "This R01 competing revision is focused on establishing the sensitivity of our novel sensor to the SARS-CoV2 protein antigen. This is a revision of our current aims in response to the NIH NIDCR NOSI for immediate and high impact research to help protect dental professionals in this COVID-19 pandemic. Our data using the plastic circuit board (PCB) sensor demonstrated capability to detect the S2 protein antigen of the SARS-CoV2 virus in concentrations as low as 0.7 fM. The long-term goal of this research is to develop a handheld, non-invasive, lowcost, point-of care, accessible sensor capable of detecting SARS-CoV2 in saliva for immediate identification of this disease. Our overall objectives in this application, which are the next steps toward attainment of our longterm goal are to: i) To optimize the analytical sensitivity and specificity of detecting SARS-CoV-2 virus in contexts relevant to clinical application and; (ii) To develop a miniaturized handheld sensor with sensitivity identical to the working PCB prototype, suitable for use in clinical field testing. This unique, translational research project is an alternative testing methodology to the current gold standard for COVID-19 of nasopharyngeal swab tests analyzed through reverse transcriptase polymerase chain reaction (RT-PCR), which is invasive and needs signal amplification of viral RNA for proper detection. Since this electrical sensor can detect the virus at such low concentrations, there is no need for amplification, and the result is rapid so individuals, particularly health care workers, can immediately implement quarantine and treatment strategies to prevent spread. The non-invasive methodology also makes periodic re-testing feasible and also allows identification of the asymptomatic reservoir in the population along with having the ability to monitor the progression of the disease through viral loading in saliva. To achieve this goal, we plan to ensure the specificity and sensitivity of the sensor to SARS-CoV2. In addition, we also plan to consolidate the electronic components into a smaller microchip to allow for portability and easy accessibility of the testing device. We propose the following aims to test our central hypothesis: Aim 1: To optimize the specificity and sensitivity of SARS-CoV-2 antigen detection in human saliva using the PCB sensor platform. Aim 2: Develop a handheld sensor for qualitative detection of SARS-CoV-2 antigen in human saliva with performance specifications equivalent to the large-scale PCB prototype.", "keywords": [ "2019-nCoV", "Antigens", "Beverages", "Bite Force", "Buffers", "COVID-19", "COVID-19 pandemic", "Ceramics", "Chemical Warfare", "Chemicals", "Clinical", "Clinical Research", "Complex", "Consumption", "Corrosion", "Corrosives", "Data", "Dental", "Dental Enamel", "Dental Porcelain", "Dental Prosthesis", "Dental caries", "Dental crowns", "Deposition", "Detection", "Devices", "Diet", "Disease", "Disease Progression", "Effectiveness", "Ensure", "Environment", "Esthetics", "Exhibits", "Failure", "Fracture", "Glass", "Goals", "Gold", "Health Personnel", "Human", "In Vitro", "Individual", "Investments", "Ions", "Lead", "Macor", "Mechanics", "Methodology", "Monitor", "National Institute of Dental and Craniofacial Research", "Oral", "Oral cavity", "Outcome Study", "Patients", "Performance", "Periodicity", "Periodontal Diseases", "Phase", "Population", "Predisposition", "Probability", "Process", "Property", "Prosthesis", "Proteins", "Public Health", "Quarantine", "Research", "Research Project Grants", "Resistance", "Reverse Transcriptase Polymerase Chain Reaction", "Saliva", "Secondary to", "Sensitivity and Specificity", "Signal Transduction", "Surface", "Swab", "Testing", "Thinness", "Translational Research", "United States National Institutes of Health", "Variant", "Viral Load result", "Virus", "biomaterial compatibility", "ceramic restoration", "clinical application", "field study", "fracture risk", "in vitro testing", "microchip", "miniaturize", "novel", "point of care", "portability", "prevent", "protective effect", "prototype", "response", "restorative dentistry", "sensor", "simulation", "treatment strategy", "vapor", "viral RNA" ], "approved": true } }, { "type": "Grant", "id": "6529", "attributes": { "award_id": "3P30AG066506-01S1", "title": "COVID-19, Social Distancing, and Cognitive Impairment in 1Florida ADRC participants", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute on Aging (NIA)" ], "program_reference_codes": [], "program_officials": [ { "id": 21874, "first_name": "NINA B.", "last_name": "SILVERBERG", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2020-06-15", "end_date": "2025-04-30", "award_amount": 154001, "principal_investigator": { "id": 21875, "first_name": "Todd E", "last_name": "Golde", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [], "awardee_organization": { "id": 158, "ror": "https://ror.org/02y3ad647", "name": "University of Florida", "address": "", "city": "", "state": "FL", "zip": "", "country": "United States", "approved": true }, "abstract": "With ~560,000 Alzheimer’s disease (AD) patients and >4 million residents >65 years old, Florida will continue to be, an epicenter of the AD epidemic in the United States. The 1Florida ADRC is a collaboration between Florida institutions, including the University of Florida (UF), Mt. Sinai Medical Center in Miami Beach (MSMC), University of Miami (UM), Florida International University (FIU), and Florida Atlantic University (FAU). The 1Florida ADRC’s global mission is to work with other ADRCs and AD stakeholders to change the understanding of AD and related dementias (ADRDs) so AD+ADRDs are more quickly and accurately diagnosed, more effectively treated, and ultimately prevented or cured. Multiple studies suggest a higher incidence of dementia among Hispanics and other underrepresented minority populations (URM). Our successful recruitment and evaluation of a majority Hispanic cohort has enabled us to begin to evaluate whether there are differences in AD+ADRDs between Hispanics and non-Hispanics in South Florida. Enhancing our understanding of dementia in ethnically and racially diverse populations is a major theme of our ADRC. The SARS-CoV-2 or severe acute respiratory syndrome coronavirus type 2 (COVID-19) pandemic could prove especially detrimental to the health and well-being of individuals with cognitive impairment due to Alzheimer’s disease and related disorders (ADRD). We believe this pandemic has placed our clinical core cohort and indeed all families affect by AD+ADRD under a great deal of stress. In this supplement, we will leverage our successful institutional and investigator partnerships to further expand our engagement and longitudinal follow up of participants with ethnic, linguistic, cultural, and genetic diversity, as well as comorbidities associated with AD (e.g., vascular disease, Lewy Body Dementia (LBD)). The specific aims of this supplement are to examine: 1) Effects of social isolation stress as a result of COVID-19 on mood, function, behavior and cognitive status 2) Effects of cognitive impairment severity on social distancing behaviors. 3) Extent of access and proficiency with video communications technologies 4) Extent of interest in participation in a telecommunications delivered supportive group program among those participants with video communications technology access.", "keywords": [ "2019-nCoV", "Affect", "Age", "Alzheimer&apos", "s Disease", "Alzheimer&apos", "s disease patient", "Alzheimer&apos", "s disease related dementia", "Behavior", "COVID-19", "COVID-19 pandemic", "Caregivers", "Clinical", "Cognition", "Cognitive", "Collaborations", "Communication", "Cultural Diversity", "Dementia", "Dependence", "Disease", "Elderly", "Epidemic", "Evaluation", "Family", "Florida", "Genetic Variation", "Health", "Hispanics", "Impaired cognition", "Incidence", "Individual", "Institution", "International", "Intervention", "Lewy Body Dementia", "Linguistics", "Medical center", "Minority", "Mission", "Moods", "Not Hispanic or Latino", "Outcome", "Participant", "Patients", "Personal Satisfaction", "Population", "Population Heterogeneity", "Readiness", "Reporting", "Research Personnel", "SARS coronavirus", "Severities", "Social Distance", "Social isolation", "Social support", "Stress", "Support Groups", "Technology", "Telecommunications", "Underrepresented Minority", "United States", "Universities", "Vascular Diseases", "Work", "accurate diagnosis", "cohort", "comorbidity", "coronavirus disease", "ethnic diversity", "follow-up", "high risk", "human old age (65+)", "interest", "low socioeconomic status", "pandemic disease", "prevent", "programs", "psychosocial", "racial diversity", "recruit", "telehealth" ], "approved": true } }, { "type": "Grant", "id": "6572", "attributes": { "award_id": "3U01AA020797-10S2", "title": "Effects of experimentally-induced reductions in alcohol consumption on brain cognitive, and clinical outcomes and motivation for changing drinking in older persons with HIV infection", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute on Alcohol Abuse and Alcoholism (NIAAA)" ], "program_reference_codes": [], "program_officials": [ { "id": 22016, "first_name": "Joe", "last_name": "Wang", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2011-09-25", "end_date": "2022-06-30", "award_amount": 147272, "principal_investigator": { "id": 22017, "first_name": "RONALD A", "last_name": "COHEN", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [ { "id": 22018, "first_name": "Robert L", "last_name": "Cook", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "awardee_organization": { "id": 158, "ror": "https://ror.org/02y3ad647", "name": "University of Florida", "address": "", "city": "", "state": "FL", "zip": "", "country": "United States", "approved": true }, "abstract": "This proposed U01 study will build on our past findings to determine the extent to which marked reductions in alcohol consumption over 4-weeks via contingency management (CM) improves cognitive performance, brain functions and pathophysiology, and HIV-associated health outcomes. HIV-associated neurocognitive dysfunction continues even with antiretroviral treatment, and even mild cognitive impairment is associated with detrimental health outcomes in older HIV+ adults. Alcohol consumption may affect the brain directly or indirectly via liver toxicity and systemic inflammation. Our past findings indicate that current heavy alcohol use is more strongly associated with cognitive/brain dysfunction among HIV+ adults than lifetime consumption, suggesting that these effects may be reversible with reductions in drinking. Towards this objective, we propose to enroll 180 HIV+ adults with heavy drinking, and then use CM with financial incentives and a wearable alcohol biosensor to maximally reduce alcohol consumption from baseline (T1) to 4-weeks later (T2). We will then conduct a motivational interview to determine perceived benefits and obstacles to drinking reduction, and conduct a final assessment 1 year later (T3), at which point persons may or may not have resumed heavy drinking. We will conduct state-of-the-art neuroimaging, cognitive, and behavioral assessments at each timepoint, and then continue to track long-term drinking and HIV outcomes in our companion Cohort (U24). The Specific Aims of this proposal are: 1) to demonstrate improved cognitive performance and brain function (fMRI) after 4-weeks of CM-induced alcohol reduction among HIV+ adults, followed by worsening of these effects 1-year later if heavy drinking resumes; 2) to demonstrate that cerebral metabolic (MRS) and neuroinflammatory (DTI-free water) markers will also improve with CM-induced alcohol reduction and worsen if drinking resumes post-CM; and 3) Determine whether perceived benefits and challenges to drinking reduction identified during motivational interviewing (MI) predict drinking reductions or relapse one-year post-CM. We will also determine whether changes in cerebral pathophysiology (MRS, DTI-FW) correspond with changes in cognition, brain function (fMRI) and serum inflammatory and liver biomarkers. In addition, we will determine which neuroimaging and baseline clinical factors are associated with long-term drinking and clinical outcomes (e.g. HIV viral suppression, liver comorbidities). In the context of this study, CM and MI are being employed as an experimental manipulation and data collection opportunity, respectively, rather than as clinical interventions per se. The A-B-A design will enable us to clearly identify whether alcohol effects on cognition and the brain are reversible, and to identify optimal strategies to promote short-term and long-term alcohol reduction in HIV+ adults. This U01 project is closely linked to the Administrative U24 (SHARC), which supports the Florida Cohort that is the source of potential participants for this study, and our Behavioral Science and Biostatistics Core (U24) that will help implement and monitor the CM, MI, and alcohol biosensor procedures.", "keywords": [ "Abstinence", "Adult", "Affect", "Age", "Aging", "Alcohol consumption", "Alcohols", "Behavior assessment", "Behavioral", "Behavioral Sciences", "Biological Markers", "Biosensor", "Biostatistics Core", "Brain", "Ceramides", "Cerebrum", "Clinical", "Cognition", "Cognitive", "Companions", "Consumption", "Data", "Data Collection", "Elderly", "Enrollment", "Florida", "Functional Magnetic Resonance Imaging", "Functional disorder", "HIV", "HIV Infections", "Health", "Heavy Drinking", "Hepatotoxicity", "Impaired cognition", "Inflammatory", "Intervention", "Link", "Liver", "Liver diseases", "Measures", "Medical", "Mental Health", "Metabolic", "Monitor", "Motivation", "Neurocognitive", "Neurocognitive Deficit", "Outcome", "Participant", "Performance", "Persons", "Plasma", "Population Heterogeneity", "Predictive Factor", "Procedures", "Relapse", "Research", "Resolution", "Rest", "Serum", "Source", "Time", "Viral", "Water", "aged", "alcohol effect", "antiretroviral therapy", "base", "brain dysfunction", "cognitive function", "cognitive performance", "cognitive testing", "cohort", "comorbidity", "contingency management", "cooking", "cytokine", "design", "drinking", "drinking behavior", "financial incentive", "functional improvement", "improved", "indexing", "mild cognitive impairment", "motivational enhancement therapy", "neuroimaging", "neuroinflammation", "psychosocial", "public health relevance", "systemic inflammatory response", "therapy adherence" ], "approved": true } } ], "meta": { "pagination": { "page": 1393, "pages": 1442, "count": 14420 } } }